
Fulltext:
80992.pdf
Embargo:
until further notice
Size:
812.3Kb
Format:
PDF
Description:
Publisher’s version
Publication year
2009Source
Biochimica et Biophysica Acta. Molecular Basis of Disease, 1792, 9, (2009), pp. 903-14ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Laboratory of Genetic, Endocrine and Metabolic Diseases
Neurology
Paediatrics - OUD tm 2017
Journal title
Biochimica et Biophysica Acta. Molecular Basis of Disease
Volume
vol. 1792
Issue
iss. 9
Page start
p. 903
Page end
p. 14
Subject
DCN 2: Functional Neurogenomics; IGMD 4: Glycostation disorders; NCMLS 4: Energy and redox metabolismAbstract
Glycosylation of proteins is one of the most important post-translational modifications. Defects in the glycan biosynthesis result in congenital malformation syndromes, also known as congenital disorders of glycosylation (CDG). Based on the iso-electric focusing patterns of plasma transferrin and apolipoprotein C-III a combined defect in N- and O-glycosylation was identified in patients with autosomal recessive cutis laxa type II (ARCL II). Disease-causing mutations were identified in the ATP6V0A2 gene, encoding the a2 subunit of the vacuolar H(+)-ATPase (V-ATPase). The V-ATPases are multi-subunit, ATP-dependent proton pumps located in membranes of cells and organels. In this article, we describe the structure, function and regulation of the V-ATPase and the phenotypes currently known to result from V-ATPase mutations. A clinical overview of cutis laxa syndromes is presented with a focus on ARCL II. Finally, the relationship between ATP6V0A2 mutations, the glycosylation defect and the ARCLII phenotype is discussed.
This item appears in the following Collection(s)
- Academic publications [227248]
- Electronic publications [108577]
- Faculty of Medical Sciences [86732]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.